Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Lei

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Antiviral Therapy|December 25, 2009
Pretreatment with pegylated interferon prevents emergence of lamivudine mutants in lamivudine-naive patients: a pilot studyErica Villa, Barbara Lei, Gloria Taliani, et al.
Molecular and Cellular Endocrinology|August 6, 2002
Phytoestrogens and liver diseaseBarbara Lei, Vera Roncaglia, Raffaella Viganò, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 6, 2018
Computed tomography or contrast-enhanced ultrasonography for follow-up of liver metastases after Cyberknife therapy?: A prospective pilot studyMaria Marsico, Tommaso Gabbani, Sarah Lunardi, et al.
International Journal of Molecular Sciences|October 16, 2025
Concomitant Autoimmune Liver Disease and Hepatic Actinomycosis: A Diagnostic Challenge-Brief Report and Review of the LiteratureGiulia Manni, Martina Pambianco, Chiara Sicuro, et al.
Cell Death & Disease|January 26, 2018
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel diseaseAlessandro Sartini, Stefano Gitto, Marcello Bianchini, et al.
Gastroenterology|December 21, 2010
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis CErica Villa, Aimilia Karampatou, Calogero Cammà, et al.
Cell Death & Disease|August 25, 2017
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical studyRosina Critelli, Fabiola Milosa, Francesca Faillaci, et al.
Gastroenterology|July 24, 2012
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosisErica Villa, Calogero Cammà, Marco Marietta, et al.
Gut|February 11, 2015
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective studyErica Villa, Rosina Critelli, Barbara Lei, et al.
Hepatology (Baltimore, Md.)|April 1, 2018
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting AntiviralsFrancesca Faillaci, Luca Marzi, Rosina Critelli, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Antiviral Therapy|December 25, 2009
Pretreatment with pegylated interferon prevents emergence of lamivudine mutants in lamivudine-naive patients: a pilot studyErica Villa, Barbara Lei, Gloria Taliani, et al.
Molecular and Cellular Endocrinology|August 6, 2002
Phytoestrogens and liver diseaseBarbara Lei, Vera Roncaglia, Raffaella Viganò, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 6, 2018
Computed tomography or contrast-enhanced ultrasonography for follow-up of liver metastases after Cyberknife therapy?: A prospective pilot studyMaria Marsico, Tommaso Gabbani, Sarah Lunardi, et al.
International Journal of Molecular Sciences|October 16, 2025
Concomitant Autoimmune Liver Disease and Hepatic Actinomycosis: A Diagnostic Challenge-Brief Report and Review of the LiteratureGiulia Manni, Martina Pambianco, Chiara Sicuro, et al.
Cell Death & Disease|January 26, 2018
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel diseaseAlessandro Sartini, Stefano Gitto, Marcello Bianchini, et al.
Gastroenterology|December 21, 2010
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis CErica Villa, Aimilia Karampatou, Calogero Cammà, et al.
Cell Death & Disease|August 25, 2017
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical studyRosina Critelli, Fabiola Milosa, Francesca Faillaci, et al.
Gastroenterology|July 24, 2012
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosisErica Villa, Calogero Cammà, Marco Marietta, et al.
Gut|February 11, 2015
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective studyErica Villa, Rosina Critelli, Barbara Lei, et al.
Hepatology (Baltimore, Md.)|April 1, 2018
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting AntiviralsFrancesca Faillaci, Luca Marzi, Rosina Critelli, et al.
Pageof 2